Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?
暂无分享,去创建一个
M. Terris | M. Cooperberg | B. Trock | A. Partin | Misop Han | S. Freedland | C. Amling | W. Aronson | C. Kane | Z. Klaassen | L. Howard | Zhaoyong Feng | Abhay A. Singh